Clinical
Jill R. Davis, MS, Bingcao Wu, MS, David M. Kern, PhD, Ozgur Tunceli, PhD, Kathleen M. Fox, PhD, John Horton, MS, Randall F. Legg, PharmD, MBA, Frank Trudo, MD, MBA
When an Outcome Is Overdetermined: Nonadherence, Utilization, and the Impetus for Research in COPD
Steven R. Feldman, MD, PhD, Bernard Goffe, MD, Gary Rice, MBA, Matthew Mitchell, PharmD, MBA, FAMCP, Mandeep Kaur, MD, MS, Debbie Robertson, MS, RDN, LDN, Debra Sierka, PharmD, Jeffrey A. Bourret, PharmD, Tamara S. Evans, PharmD, MPH, BCPS, Alice Gottlieb, MD, PhD
The Challenge of Managing Specialty Drugs for Psoriasis
Qing Huang, PhD, MHS, Michael Grabner, PhD, Robert J. Sanchez, PhD, Vincent J. Willey, PharmD, Mark J. Cziraky, PharmD, Swetha R. Palli, MS, Thomas P. Power, MD, FACC, MRCPI
Using Statin Therapy to Reduce Atherosclerotic Cardiovascular Disease Risk
Rajiv Mallick, PhD, Aditya Raju, MS, BPharm, Chelsey Campbell, PharmD, MBA, Rashad Carlton, PharmD, MSPH, David Wright, MD, Kimberly Boswell, MD, Michael Eaddy, PharmD, PhD
Important Insights from Real-World Treatment Patterns and Outcomes for Varicose Veins Management
Maxine D. Fisher, PhD, Yamina Rajput, MS, Tao Gu, PhD, Joseph R. Singer, MD, Amanda R. Marshall, BS, Seonyoung Ryu, PharmD, John Barron, PharmD, Catherine MacLean, MD, PhD, Josephine N. Tran, PharmD, MS, Young In Park, DO, Shalin Pandya, DO, Navin John Muliyil, DO, Brandon David Jensen, DO, Kovin Huynh, DO, Quang T. Nguyen, DO, FACP, FACE, FTOS
Provider and Payer Collaboration Needed to Ensure Adherence to Recommended Eye Examinations in Patients with Diabetes
Marie-Hélène Lafeuille, MA, Christian Frois, PhD, Michel Cloutier, PhD, Mei Sheng Duh, MPH, ScD, Patrick Lefebvre, MA, Jacqueline Pesa, PhD, MPH, Zoe Clancy, PharmD, John Fastenau, RPh, MPH, Mike Durkin, MSc
Patient Characteristics, Adherence, and a Metric of Organizational Performance in Behavioral Health
John Barron, PharmD, Yiqiong Xie, PhD, Sze-jung Wu, PhD, Jeff White, PharmD, Joseph R. Singer, MD, Bernard Tulsi, MSc, Alan Rosenberg, MD
Evaluating the True Value of High-Cost Therapies for Hepatitis C Infection
Daniel B. Ng, PharmD, MBA, Melissa McCart, PharmD, MS, Christopher Klein, BS, Chelsey Campbell, PharmD, MBA, Robert Schoenhaus, PharmD, Todd Berner, MD
Implications of Big Data Analysis in the Real-World Setting: The Case of Overactive Bladder Treatment
Jordan D. Haag, PharmD, RPh, Amanda Z. Davis, PharmD, RPh, Robert W. Hoel, PharmD, RPh, Jeffrey J. Armon, PharmD, RPh, Laura J. Odell, PharmD, RPh, Ross A. Dierkhising, MS, Paul Y. Takahashi, MD
A Systematic Approach to Medication Therapy Management in Elderly Patients with Chronic Diseases Can Improve Outcomes
Abdullah K. Alahmari, BPharm, PhD candidate, Ziyad S. Almalki, BPharm, PhD candidate, Ahmed K. Alahmari,, Medical Student, Jeff J. Guo, BPharm, PhD
Better Patient Education Needed Regarding Thromboembolic Events Risk in Patients with Cancer
